Earlier this month, David Bronner, CEO of soap brand Dr. Bronner’s, was hopping a short flight from Southern California up to Portland. As a dedicated supporter of Oregon Measure 109—which would legalize psilocybin-producing mushrooms for therapeutic use—Bronner wanted to be on hand for the ballot initiative’s historic passage.
As the chief of a cultishly popular boutique skincare brand known as much for its castile soap as for its political activism, Bronner was also excited to have filled his carry-on bag with some samples of his latest product: a limited-edition bar of soap that, so far as anyone knows, is an industry first.
It
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in